These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23459219)

  • 21. Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
    Bina S; Muldoon S; Bünger R
    Eur J Anaesthesiol; 2008 Jan; 25(1):48-57. PubMed ID: 17686208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels.
    Priori SG; Napolitano C
    J Clin Invest; 2005 Aug; 115(8):2033-8. PubMed ID: 16075044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is lymphocyte adenosine a diagnostic marker of clinical malignant hyperthermia? A pilot study.
    Bina S; Capacchione J; Munkhuu B; Muldoon S; Bünger R
    Crit Care Med; 2015 Mar; 43(3):584-93. PubMed ID: 25479114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
    Monnier N; Kozak-Ribbens G; Krivosic-Horber R; Nivoche Y; Qi D; Kraev N; Loke J; Sharma P; Tegazzin V; Figarella-Branger D; Roméro N; Mezin P; Bendahan D; Payen JF; Depret T; Maclennan DH; Lunardi J
    Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in RYR1 in malignant hyperthermia and central core disease.
    Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
    Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.
    Kraeva N; Riazi S; Loke J; Frodis W; Crossan ML; Nolan K; Kraev A; Maclennan DH
    Can J Anaesth; 2011 Jun; 58(6):504-13. PubMed ID: 21455645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia.
    Schiemann AH; Dürholt EM; Pollock N; Stowell KM
    Br J Anaesth; 2013 Jan; 110(1):122-7. PubMed ID: 23035052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.
    MacLennan DH; Duff C; Zorzato F; Fujii J; Phillips M; Korneluk RG; Frodis W; Britt BA; Worton RG
    Nature; 1990 Feb; 343(6258):559-61. PubMed ID: 1967823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Functional Analysis of RYR1 Variants in a Family with a Suspected Myopathy and Associated Malignant Hyperthermia.
    Schiemann AH; Roesl C; Pollock N; Langton E; Bulger T; Stowell KM
    J Neuromuscul Dis; 2020; 7(1):51-60. PubMed ID: 31903994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype comparison of the Swiss malignant hyperthermia population.
    Girard T; Urwyler A; Censier K; Mueller CR; Zorzato F; Treves S
    Hum Mutat; 2001 Oct; 18(4):357-8. PubMed ID: 11668625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
    Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
    Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia.
    White R; Schiemann AH; Burling SM; Bjorksten A; Bulger T; Gillies R; Hopkins PM; Kamsteeg EJ; Machon RG; Massey S; Miller D; Perry M; Snoeck MMJ; Stephens J; Street N; van den Bersselaar LR; Stowell KM
    Br J Anaesth; 2022 Dec; 129(6):879-888. PubMed ID: 36208971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease.
    Ducreux S; Zorzato F; Müller C; Sewry C; Muntoni F; Quinlivan R; Restagno G; Girard T; Treves S
    J Biol Chem; 2004 Oct; 279(42):43838-46. PubMed ID: 15299003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propofol-induced changes in myoplasmic calcium concentrations in cultured human skeletal muscles from RYR1 mutation carriers.
    Migita T; Mukaida K; Kawamoto M; Kobayashi M; Nishino I; Yuget O
    Anaesth Intensive Care; 2007 Dec; 35(6):894-8. PubMed ID: 18084979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the pathogenicity of RYR1 variants in malignant hyperthermia.
    Merritt A; Booms P; Shaw MA; Miller DM; Daly C; Bilmen JG; Stowell KM; Allen PD; Steele DS; Hopkins PM
    Br J Anaesth; 2017 Apr; 118(4):533-543. PubMed ID: 28403410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.
    Giulivi C; Ross-Inta C; Omanska-Klusek A; Napoli E; Sakaguchi D; Barrientos G; Allen PD; Pessah IN
    J Biol Chem; 2011 Jan; 286(1):99-113. PubMed ID: 20978128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hyperthermia: a pharmacogenetic disorder.
    Stowell KM
    Pharmacogenomics; 2008 Nov; 9(11):1657-72. PubMed ID: 19018722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and functional analysis of the RYR1 mutation p.Thr84Met revealed a susceptibility to malignant hyperthermia.
    Kondo T; Yasuda T; Mukaida K; Otsuki S; Kanzaki R; Miyoshi H; Hamada H; Nishino I; Kawamoto M
    J Anesth; 2018 Apr; 32(2):174-181. PubMed ID: 29344738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.